Gossamer Bio, Inc. (FRA:4GB)
Germany · Delayed Price · Currency is EUR 2.724
-0.082 (-2.92%)
At close: Dec 1, 2025
Gossamer Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -156.16 | -56.53 | -179.82 | -229.38 | -234 | -243.36 | Upgrade |
Depreciation & Amortization | 1.85 | 4.15 | 4.39 | 4.43 | 5.17 | 4.27 | Upgrade |
Other Amortization | 0.97 | 1.09 | 1.32 | 1.16 | 6.73 | 3.86 | Upgrade |
Loss (Gain) From Sale of Assets | 0.19 | 0.81 | 0.73 | - | 0.02 | - | Upgrade |
Asset Writedown & Restructuring Costs | 7.48 | - | 10 | 0.07 | 0.08 | 23.38 | Upgrade |
Loss (Gain) From Sale of Investments | -9.56 | -13.06 | -9.45 | -1.41 | 0.34 | -0.16 | Upgrade |
Stock-Based Compensation | 12.62 | 20.62 | 28.52 | 42.55 | 32.01 | 38.75 | Upgrade |
Change in Accounts Receivable | -2.66 | -5.34 | - | - | - | - | Upgrade |
Change in Accounts Payable | -4.49 | -1.66 | 3.99 | -1.81 | -4.43 | 6.98 | Upgrade |
Change in Unearned Revenue | -13.05 | 55.92 | - | - | - | - | Upgrade |
Change in Other Net Operating Assets | 4.38 | -9.47 | -18.83 | -2.65 | 5.2 | -10.08 | Upgrade |
Operating Cash Flow | -158.43 | -3.47 | -159.16 | -187.03 | -188.89 | -176.36 | Upgrade |
Capital Expenditures | -0.08 | - | - | -0.41 | -1.55 | -1.5 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -0.07 | -0.08 | -23.38 | Upgrade |
Investment in Securities | 136.5 | 29.02 | -110.97 | -0.56 | -115.81 | 240.23 | Upgrade |
Investing Cash Flow | 136.42 | 29.02 | -110.97 | -1.04 | -117.43 | 215.34 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 193.6 | Upgrade |
Long-Term Debt Repaid | - | -12.58 | -11.61 | -5.81 | - | - | Upgrade |
Net Debt Issued (Repaid) | - | -12.58 | -11.61 | -5.81 | - | 193.6 | Upgrade |
Issuance of Common Stock | 2.47 | 0.63 | 201.77 | 122.9 | 3.33 | 118.94 | Upgrade |
Other Financing Activities | - | 0.46 | - | - | - | - | Upgrade |
Financing Cash Flow | 2.47 | -11.49 | 190.15 | 117.09 | 3.33 | 312.54 | Upgrade |
Foreign Exchange Rate Adjustments | 0.01 | -0.1 | 0.11 | -0.52 | -0.17 | 0.01 | Upgrade |
Net Cash Flow | -19.53 | 13.97 | -79.86 | -71.49 | -303.15 | 351.53 | Upgrade |
Free Cash Flow | -158.51 | -3.47 | -159.16 | -187.44 | -190.44 | -177.86 | Upgrade |
Free Cash Flow Margin | -359.84% | -3.02% | - | - | - | - | Upgrade |
Free Cash Flow Per Share | -0.70 | -0.01 | -1.04 | -2.22 | -2.54 | -2.60 | Upgrade |
Cash Interest Paid | 10 | 10.56 | 12.29 | 12.71 | 12.74 | 7.87 | Upgrade |
Levered Free Cash Flow | -82 | -16.7 | -84.66 | -99.55 | -99.82 | -119.24 | Upgrade |
Unlevered Free Cash Flow | -76.12 | -10.59 | -77.54 | -92.04 | -94.4 | -115.18 | Upgrade |
Change in Working Capital | -15.82 | 39.46 | -14.84 | -4.46 | 0.77 | -3.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.